ATI INC. DL-,01/ US01741R1023 /
07/06/2024 08:00:46 | Chg. -0.80 | Volume | Bid20:59:53 | Ask20:59:53 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
54.38EUR | -1.45% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 6.72 bill.EUR | - | - |
GlobeNewswire
30/05
Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire
23/05
Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire
21/05
Acoustic Technology, Inc. (ATI Systems) Revolutionizes Emergency Communication with Unique Advanced ...
GlobeNewswire
07/05
Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire
27/03
William & Mary Campus Mass Notification Drill Using ATI Systems’ Mass Notification Solution
GlobeNewswire
12/03
Researchers Publish Manuscript on the Prevention and Emergency Response to Tularemia Outbreaks
GlobeNewswire
13/02
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024
GlobeNewswire
06/02
Seoul Robotics to Pursue Initial Public Offering with Samsung Securities as it Expands OEM Partnersh...
GlobeNewswire
27/12/2023
Eco Bright Future, Inc. Announces Signing of "Letter-of-Intent" With United Heritage, Sociedad Anoni...
GlobeNewswire
12/12/2023
Astrotech Announces Exciting New Technology Application and Introduces New Subsidiary
GlobeNewswire
13/11/2023
Aclaris Therapeutics Announces Top-line Results from 12-Week Phase 2b Trial of Oral Zunsemetinib (AT...
GlobeNewswire
06/11/2023
Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
GlobeNewswire
27/10/2023
Strategic Advisory Board Elevates sureti’s Property Claims Resolution Capabilities
GlobeNewswire
25/10/2023
Excision BioTherapeutics Presents Positive Interim Clinical Data from Ongoing Phase 1/2 Trial of EBT...
GlobeNewswire
23/10/2023
ATI PHYSICAL THERAPY INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti...
GlobeNewswire
19/10/2023
Excision BioTherapeutics Announces Presentation of Interim Clinical Data for EBT-101 in Latent HIV a...